Overview of therapies for prevention of restenosis after coronary interventions

Pharmacology & Therapeutics
S M GarasN A Scott

Abstract

Coronary artery disease is a leading cause of morbidity and mortality in the United States and across the world. The economic impact of coronary artery disease is staggering and on the rise. Percutaneous transluminal coronary angioplasty is widely used to treat severe, symptomatic coronary stenosis. The Achilles heel of angioplasty is restenosis of those treated arteries. As a result, numerous therapies, including mechanical and pharmacological approaches, to prevent restenosis have been studied. A greater understanding of the pathophysiology of restenosis has enhanced the success of these therapeutic approaches. To date, the most important and successful approach to limit restenosis has been the use of coronary stents. Stents have reduced the rate of restenosis from approximately 50% down to 20-30%. However, in-stent restenosis presents a new and an even more challenging dilemma. The success of adjunctive drug therapy has been promising, but, as of yet, very limited. Antithrombotic agents have reduced acute thrombosis and many of the acute complications of angioplasty. New approaches and therapies are very encouraging, and provide great hope in the treatment of restenosis. Brachytherapy has shown success in the treatment of in...Continue Reading

References

Jan 1, 1976·Acta Medica Scandinavica·H O BangN Hjøorne
Jun 11, 1992·Journal of the American College of Cardiology·J H O'KeefeG O Hartzler
Feb 25, 1991·The American Journal of Cardiology·J H O'KeefeB D McCallister
May 1, 1991·Journal of the American College of Cardiology·J H IpJ H Chesebro
Mar 1, 1990·Journal of the American College of Cardiology·M L KnudtsonH J Duff
Dec 1, 1990·Biochemical Pharmacology·K HanasakiH Arita
Aug 1, 1989·Journal of Vascular Surgery·A ChervuT Henderson
Dec 1, 1986·Journal of the American College of Cardiology·H B WhitworthA R Gruentzig
Sep 15, 1988·The New England Journal of Medicine·J A OatesL J Roberts
Mar 3, 1988·The New England Journal of Medicine·A Leaf, P C Weber
Feb 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·G M NemecekM A Moskowitz
Feb 1, 1993·Journal of Cardiovascular Pharmacology·C P SungE H Ohlstein
Nov 17, 1994·The New England Journal of Medicine·W S WeintraubS J DeMaio
Nov 1, 1994·Circulation·A LeafA E Raizner

❮ Previous
Next ❯

Citations

Nov 29, 2002·Seminars in Roentgenology·Stanley G Cooper, Constantinos T Sofocleous
Aug 24, 2004·Nature Cell Biology·Kuang-Hueih ChenJian Tang
Dec 20, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Dikla Gutman, Gershon Golomb
Mar 3, 2010·Colloids and Surfaces. B, Biointerfaces·Chang-Jiang PanNan Huang
Jun 23, 2009·Colloids and Surfaces. B, Biointerfaces·Chang-Jiang PanNan Huang
Nov 5, 2004·The Journal of Pharmacy and Pharmacology·Peter BirkenhauerBruno Gander
Jul 25, 2009·Journal of Interventional Cardiology·Yingying HuangSabareeswaran Arumugam
Oct 8, 2009·Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging·Peter A Rasmussen, UNKNOWN US Wingspan Registry Group
Feb 14, 2008·IEEE Transactions on Bio-medical Engineering·Zachary G ForbesGary Friedman
Oct 19, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ch J PanN Huang
Dec 16, 2011·Journal of Vascular Surgery·Timothy E DeglauWilliam R Wagner
Apr 21, 2017·The FEBS Journal·Boqian ZhuChengchun Tang
Jan 7, 2009·Therapeutic Advances in Cardiovascular Disease·Santiago Jimenez-ValeroJose López-Sendón
Mar 22, 2013·Neurointervention·Soonchan ParkDae Chul Suh
Oct 24, 2017·Drug Delivery and Translational Research·Gil AizikGershon Golomb
Sep 20, 2011·Menopause : the Journal of the North American Menopause Society·David F Archer
Dec 19, 2006·Cardiology in Review·Leo SlavinJonathan M Tobis
Jan 17, 2019·International Journal of Molecular Sciences·Dongdong Wang, Atanas G Atanasov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Related Papers

Arteriosclerosis, Thrombosis, and Vascular Biology
Frederick G P Welt, Campbell Rogers
© 2022 Meta ULC. All rights reserved